CymaBay Therapeutics, Inc.

CIK 1042074 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CymaBay Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Apr 1, 202415-12G0001104659-24-041347
Mar 28, 2024EFFECT9999999995-24-000749
Mar 28, 2024EFFECT9999999995-24-000748
Mar 28, 2024EFFECT9999999995-24-000747
Mar 28, 2024EFFECT9999999995-24-000750
Mar 28, 2024EFFECT9999999995-24-000752
Mar 22, 2024S-8 POS0001193125-24-075403
Mar 22, 202440000950170-24-035447
Mar 22, 202440000950170-24-035460
Mar 22, 202440000950170-24-035435
Mar 22, 202440000950170-24-035458
Mar 22, 2024S-8 POS0001193125-24-075407
Mar 22, 2024S-8 POS0001193125-24-075372
Mar 22, 2024S-8 POS0001193125-24-075393
Mar 22, 2024POS AM0001193125-24-075257
Mar 22, 2024S-8 POS0001193125-24-075382
Mar 22, 2024S-8 POS0001193125-24-075392
Mar 22, 202440000950170-24-035468
Mar 22, 202440000950170-24-035446
Mar 22, 2024S-8 POS0001193125-24-075404
Mar 22, 2024POS AM0001193125-24-075270
Mar 22, 20248-K0001193125-24-074701
Mar 22, 2024SC 14D9/A0001193125-24-074582
Mar 22, 2024POSASR0001193125-24-075318
Mar 22, 2024S-8 POS0001193125-24-075381